Search for: "Clinical Data, Inc." Results 581 - 600 of 1,006
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Feb 2014, 12:32 pm
Each facility's profile displays health and fire violations, performance in important clinical categories and how much time nursing staff spends with residents. [read post]
9 Feb 2014, 6:18 am by David Jensen
Stanford and Stanford faculty-founded companies such as Stem Cells Inc, are blatantly promoted over others. [read post]
4 Jan 2014, 9:47 am by Schachtman
Selikoff had a general practice clinic in Paterson, New Jersey, in the 1950s, when his practice and his litigation support efforts were noticed by the asbestos insulation workers’ union. [read post]
26 Dec 2013, 9:49 pm by Cynthia Marcotte Stamer
Stamer also regularly works with OCR, FTC, USSS, FBI and state and local law enforcement on privacy, data security, health care, benefits and insurance and other matters, publishes and speaks extensively on medical and other privacy and data security, health and managed care industry regulatory, staffing and human resources, compensation and benefits, technology, public policy, reimbursement and other operations and risk management concerns. [read post]
19 Dec 2013, 6:12 am
 FDA, ODE, “Summary Of Safety And Effectiveness Data (SSED) − Clinical Section Checklist,” at 6 (June 10, 2010) (emphasis added). [read post]
26 Nov 2013, 4:45 pm by Barry Sookman
The objective of the survey was to collect data to identify the current courses, faculty, programs, and research focus of IP educators in Canada. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
For example, when a J&J study of Risperdal showed a significant risk of strokes and other adverse events in elderly dementia patients, the complaint alleges that Janssen combined the study data with other studies to make it appear that there was a lower overall risk of adverse events. [read post]
4 Nov 2013, 9:08 am
Zimmer, Inc., 299 P.3d 463 (Okla. 2013), could be used to expand traditional tort causes of action under Oklahoma law in all sorts of novel and bizarre ways.Well, we still have that general concern, but if Clineis any indication, off-label use is not going to be one of those areas. [read post]
4 Nov 2013, 3:04 am by Ben Vernia
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
1 Oct 2013, 11:41 am by Cynthia Marcotte Stamer
  See Observations Noted During The OIG Review Of CMS’s Implementation Of The Health Insurance Exchange—Data Services Hub. [read post]
30 Sep 2013, 2:43 pm by Mark Zamora
Pfizer Inc's antibacterial drug Tygacil increases the risk of death whether used as authorized by the U.S. [read post]
19 Sep 2013, 9:53 am by Bexis
  [The expert] used aggregate data and statistical approaches to link patterns in promotional spending to patterns in prescribing for the drug. [read post]
16 Sep 2013, 3:21 pm by Cynthia Marcotte Stamer
Stamer is widely recognized for her extensive work, publications, and thought leadership on HIPAA and other privacy and data security issues. [read post]
4 Sep 2013, 10:15 am by Joy Waltemath
Noting that an investigation summary appeared one-sided and result-driven because it had all of an African-American subordinate’s allegations that her supervisor was racist, but none of the supervisor’s explanations as to why she disciplined the subordinate the way she did, a federal district court in Texas denied an employer’s motion for summary judgment on the supervisor’s age discrimination claim (Bautista v Quest Diagnostics Clinical Laboratories, Inc,… [read post]